Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -94.08% is 56% above its 5-year average of -212.10%, near the high end of its 5-year range (-2292.86%–-51.24%).
As of the fiscal period ended Tuesday, June 30, 2026. 47.19% above its 12-month average of -178.15%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -94.08%.
RETURN ON INVESTED CAPITAL (ROIC)
-94.08%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-178.15%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-302.04%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-212.10%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+47.19%
CURRENT VS 3Y AVG
+68.85%
CURRENT VS 5Y AVG
+55.64%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-32.63%
median of 618 covered companies
CURRENT VS SECTOR MEDIAN
-188.31%
vs the sector median at left
Acurx Pharmaceuticals, Inc.
Market Cap
$5.57M
Return on Invested Capital (ROIC)
-94.08%
TTM Avg
-178.15%
3Y Avg
-302.04%
5Y Avg
-212.10%
Market Cap
$5.68M
Return on Invested Capital (ROIC)
-84.15%
TTM Avg
-84.15%
3Y Avg
-84.15%
5Y Avg
-84.15%
Market Cap
$5.84M
Return on Invested Capital (ROIC)
-80.65%
TTM Avg
-65.64%
3Y Avg
-61.70%
5Y Avg
-66.02%
Market Cap
$5.36M
Return on Invested Capital (ROIC)
-156.69%
TTM Avg
-654.50%
3Y Avg
-599.09%
5Y Avg
-420.09%
Market Cap
$5.32M
Return on Invested Capital (ROIC)
-27.41%
TTM Avg
-21.46%
3Y Avg
-17.98%
5Y Avg
-12.44%
Market Cap
$5.81M
Return on Invested Capital (ROIC)
-122.15%
TTM Avg
-90.24%
3Y Avg
-109.34%
5Y Avg
-347.01%
Market Cap
$5.26M
Return on Invested Capital (ROIC)
-179.58%
TTM Avg
-259.96%
3Y Avg
-220.56%
5Y Avg
-170.22%
Market Cap
$5.21M
Return on Invested Capital (ROIC)
-225.12%
TTM Avg
-13.17%
3Y Avg
-9.09%
5Y Avg
-9.09%
Market Cap
$5.19M
Return on Invested Capital (ROIC)
N/A
TTM Avg
-67.32%
3Y Avg
-73.33%
5Y Avg
-73.33%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Acurx Pharmaceuticals, Inc. (ACXP) | $5.57M | -94.08% | -178.15% | -302.04% | -212.10% |
| Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR)vs › | $5.68M | -84.15% | -84.15% | -84.15% | -84.15% |
| enVVeno Medical Corporation (NVNO)vs › | $5.84M | -80.65% | -65.64% | -61.70% | -66.02% |
| Alzamend Neuro Inc (ALZN)vs › | $5.36M | -156.69% | -654.50% | -599.09% | -420.09% |
| Gelteq Limited Ordinary Shares (GELS)vs › | $5.32M | -27.41% | -21.46% | -17.98% | -12.44% |
| Lucyd, Inc (LUCY)vs › | $5.81M | -122.15% | -90.24% | -109.34% | -347.01% |
| Intelligent Bio Solutions Inc. (INBS)vs › | $5.26M | -179.58% | -259.96% | -220.56% | -170.22% |
| Liminatus Pharma, Inc. Class A Common Stock (LIMN)vs › | $5.21M | -225.12% | -13.17% | -9.09% | -9.09% |
| Lunai Bioworks Inc. (LNAI)vs › | $5.19M | N/A | -67.32% | -73.33% | -73.33% |
| Enlivex Therapeutics Ltd. (ENLV)vs › | $5.99M | -0.32% | -32.77% | -50.72% | -41.90% |
ROIC
-94.1%
ROE
-92.1%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -94.08% |
| 2026-03-31 | -108.82% |
| 2025-12-31 | -153.07% |
| 2025-09-30 | -253.76% |
| 2025-06-30 | -281.02% |
| 2025-03-31 | -513.77% |
| 2024-12-31 | -2292.86% |
| 2024-09-30 | -616.99% |
| 2024-06-30 | -488.12% |
| 2024-03-31 | -267.61% |
| 2023-12-31 | -312.38% |
| 2023-09-30 | -323.37% |
| 2023-06-30 | -211.54% |
| 2023-03-31 | -232.06% |
| 2022-12-31 | -165.31% |
| 2022-09-30 | -117.37% |
| 2022-06-30 | -142.96% |
| 2022-03-31 | -131.07% |
| 2021-12-31 | -103.26% |
| 2021-09-30 | -79.01% |
| 2021-06-30 | -51.24% |
| 2021-03-31 | -188.96% |
| 2020-12-31 | -166.18% |
